AI Verdict
IBP has stronger fundamentals based on our AI analysis.
IBRX vs IBP Fundamental Comparison
| Metric | IBRX | IBP |
|---|---|---|
| Revenue | $113.3M | $3.0B |
| Net Income | $-351.4M | $265.4M |
| Net Margin | -310.2% | 8.9% |
| ROE | N/A | 37.4% |
| ROA | -70.0% | 12.8% |
| Current Ratio | 5.10x | 3.03x |
| Debt/Equity | N/A | 1.25x |
| EPS | $-0.38 | $9.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IBRX vs IBP: Frequently Asked Questions
Is IBRX or IBP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IBP has stronger fundamentals. IBRX is rated STRONG SELL (92% confidence) while IBP is rated BUY (78% confidence). This is not investment advice.
How does IBRX compare to IBP fundamentally?
ImmunityBio, Inc. has ROE of N/A vs Installed Building Products, Inc.'s 37.4%. Net margins are -310.2% vs 8.9% respectively.
Which stock pays higher dividends, IBRX or IBP?
IBRX has a dividend yield of N/A or no dividend while IBP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IBRX or IBP for long term?
For long-term investing, consider that IBRX has STRONG SELL rating with 92% confidence, while IBP has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IBRX vs IBP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IBRX vs IBP, the AI consensus favors IBP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.